[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer (Q43521805)

24 November 2017

[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer (English)

1 reference

positron emission tomography

24 November 2017

1 reference

3

1 reference

24 November 2017

Dhital K

1

1 reference

24 November 2017

Saunders CA

series ordinal

2

1 reference

24 November 2017

O'Doherty MJ

series ordinal

4

1 reference

24 November 2017

Dussek J

series ordinal

5

1 reference

24 November 2017

1 October 2000

1 reference

European Journal of Cardio-Thoracic Surgery

24 November 2017

1 reference

24 November 2017

18

1 reference

24 November 2017

4

1 reference

24 November 2017

425-428

1 reference

Current role of positron emission tomography in thoracic oncology

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

Positron emission tomography in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2800%2900535-2

7 January 2021

10.1016/S1010-7940(00)00535-2

Identifiers

DOI

1 reference

release_oqrbdi2vsre2xcsq2saygbgktm

24 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oqrbdi2vsre2xcsq2saygbgktm

24 November 2022

mapped directly with Wikidata item

1 reference